Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Lucid Diagnostics Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 30 | 34 | +4 |
| Shares | 2.07M | 1.99M | −77.5K (−3.7%) |
| Value | $1.69M | $1.64M | −$52.2K (−3.1%) |
New holders (8)
Institutions that held Lucid Diagnostics Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lido Advisors, LLC | 68,016 | $55.8K | 0.00% |
| Two Sigma Securities, LLC | 27,753 | $22.8K | 0.00% |
| Axiom Advisory, LLC | 14,958 | $12.9K | 0.00% |
| Resources Investment Advisors, LLC. | 13,530 | $11.1K | 0.00% |
| First Manhattan Co | 12,600 | $10.3K | 0.00% |
| Byrne Asset Management LLC | 11,000 | $9.56K | 0.01% |
| International Assets Investment Management, LLC | 1,000 | $820 | 0.00% |
| GWM Advisors LLC | 2 | $2 | 0.00% |
Sold out (4)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Jane Street Group, LLC | 122,013 | $98.8K |
| HRT Financial LP | 63,035 | $51.0K |
| Citadel Advisors LLC | 29,301 | $23.7K |
| Newbridge Financial Services Group, Inc. | 50 | $40 |